Cellulitis clinical trials
The registry lists 160 studies for Cellulitis across more than 10 countries. 14 are recruiting or about to start. 79 of them are mainly about Cellulitis (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-20.
Get an email when these change. Save the Cellulitis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
GlaxoSmithKline (9) · Pfizer (4) · Durata Therapeutics Inc., an affiliate of Allergan plc (3) · Ohio State University (3) · Ottawa Hospital Research Institute (3) · Brigham and Women's Hospital (3) · Melinta Therapeutics, Inc. (3) · Indústria Brasileira Equipamentos Médicos - IBRAMED (3)
What is being tested here
Drugs under test in Cellulitis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Clindamycin | 1 | 0 | 4 |
| Moxifloxacin | 1 | 1 | 2 |
| Naproxen | 1 | 1 | 1 |
| Daptomycin | 0 | 2 | 5 |
| Ceftaroline | 0 | 4 | 5 |
| Dalbavancin | 0 | 3 | 4 |
| Tigecycline | 0 | 2 | 3 |
| Cephalexin | 0 | 0 | 3 |
| Mupirocin | 0 | 1 | 2 |
| Oritavancin | 0 | 0 | 2 |
Drug classes tested here Corticosteroids 4
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 5
- Nov 2026Perspectives on Antibiotics and Tracking Symptoms in Children · Murdoch Childrens Research Institute
- Nov 2026Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) · Duke University
- Jan 2027Intravenous Versus Oral Treatment of the Main Acute Infections · University of Southern Denmark
- Jan 2027Moxifloxacin Versus Clindamycin in the Management of Odontogenic Maxillofacial Infectious Processes · Nishtar Medical University
- Sep 2027Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric Conditions · University Hospital, Lille
Who these studies take
Of the 7 Cellulitis studies recruiting now, 4 (57%) set no upper age limit and 3 (43%) stop at 75 or younger. 4 (57%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (29%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 4 (57%) | 4 (57%) |
| 18 | 5 (71%) | 5 (71%) |
| 30 | 4 (57%) | 4 (57%) |
| 40 | 4 (57%) | 4 (57%) |
| 50 | 4 (57%) | 4 (57%) |
| 65 | 4 (57%) | 4 (57%) |
| 75 | 4 (57%) | 4 (57%) |
| 85 | 4 (57%) | 4 (57%) |
Across all 160 studies, recruiting or not: 28% stop at 75 or younger and 24% at 65; 31% take children; 8% are for women only and 1% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Cellulitis studies take
Of 18 interventional studies with no phase under Cellulitis, half reached primary completion within 24 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 24 mo8–27 · 18 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 50 of 160. Browse all 160 → or search them.
- Naproxen Versus Placebo as Adjunct Treatment of CellulitisNot yet recruitingNCT07665476Phase 31 country
- Moxifloxacin Versus Clindamycin in the Management of Odontogenic Maxillofacial Infectious ProcessesNot yet recruitingNCT07810244Not applicable1 country
- Perspectives on Antibiotics and Tracking Symptoms in ChildrenRecruitingNCT07093749Not applicable1 country
- Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic DermatitisRecruitingNCT07333378Not applicable1 country
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)RecruitingNCT042784042 countries
- Clinical Efficacy of Stopping Oral Antibiotics When Symptoms Stop, Compared to 'Finishing the Course'RecruitingNCT07532941Phase 41 country
- Validation of the Use of the Arteriovenous Tension Difference in CO2 Under Hyperbaric ConditionsNot yet recruitingNCT074920301 country
- Intravenous Versus Oral Treatment of the Main Acute InfectionsRecruitingNCT06715306Not applicable1 country
- Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled TrialRecruitingNCT05899140Phase 41 country
- Peri-appendiceal Abscess and Phlegmon in Acute Complicated Appendicitis PatientsNot yet recruitingNCT06490185
- Acutelines: a Large Data-/Biobank of Acute and Emergency MedicineRecruitingNCT046150651 country
- STASSH - TRAUMA - Absorbable vs Non-Absorbable Sutures in Trauma Hand SurgeryNot yet recruitingNCT06247761Not applicable
- Clinical Outcomes in Patients With Infection by Resistant MicroorganismEnrolling by invitationNCT058800691 country
- Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)Not yet recruitingNCT054733251 country
- Discharge Stewardship in Children's HospitalsCompletedNCT05826873Not applicable1 country
- Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin InfectionsCompletedNCT00368537Phase 412 countries
- High-dose Cephalexin for Cellulitis (HI-DOCC)CompletedNCT05852262Phase 41 country
- RF Microneedling With Multi-Depth Targeting Per Insertion for The Treatment of CelluliteCompletedNCT06283056Not applicable1 country
- Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)CompletedNCT06526884Not applicable1 country
- Oral Moxifloxacin Versus Cefazolin and Oral Probenecid in the Management of Skin and Soft Tissue Infections in the Emergency DepartmentCompletedNCT00323219Phase 31 country
- Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED SettingCompletedNCT03036358Not applicable1 country
- The Personalised Antibiotic Duration for Cellulitis (PAD-C) StudyCompletedNCT050232001 country
- Study Assessing Impact of Dermatology Consultation for Patients Admitted With CellulitisCompletedNCT01706913Not applicable1 country
- The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin BreakdownCompletedNCT03929224Phase 41 country
- Short and Long Term Outcomes of Doxycycline Versus Trimethoprim-Sulfamethoxazole for Skin and Soft Tissue Infections TreatmentCompletedNCT03637400Phase 21 country
- Burden of Recreational Water Illness Due to Exposure to Cyanobacteria and Their Toxins in Freshwater Beaches in CanadaActive, not recruitingNCT065791701 country
- Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary CareCompletedNCT05226260Not applicable1 country
- The Effect of Histopathologic Analysis and Tissue Cultures on Inpatient Management of Cellulitis and PseudocellulitisCompletedNCT037858341 country
- A Randomized Clinical Trial to Prevent Recurrent CA-MRSA InfectionCompletedNCT00560599Phase 31 country
- High-dose vs. Standard-dose Cephalexin for CellulitisCompletedNCT04471246Phase 41 country
- RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue ReconstructionCompletedNCT04091672Not applicable1 country
- Continuous Temperature Telemonitoring of Patients With COVID-19 and Other Infectious Diseases in Hospital at Home Using VitureCompletedNCT059599281 country
- A Study to Evaluate the Safety of a Single Intravenous (IV) Dose of Orbactiv (Oritavancin) in Participants on Chronic Warfarin Therapy Being Treated For Acute Bacterial Skin and Skin Structure Infection (ABSSSI)CompletedNCT02452918Phase 41 country
- Skin Inflammation and PK of AzithromycinStatus unknownNCT06170983Not applicable
- Utility of Thermal Imaging in Diagnosis of Cellulitis for Lower Extremity Complaints in the Emergency DepartmentCompletedNCT049282351 country
- Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in ChinaCompletedNCT06149117Phase 41 country
- Improving Short Course Treatment for Common Pediatric InfectionsCompletedNCT06087809Not applicable1 country
- The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia AreataCompletedNCT042395211 country
- Hospital Avoidance Strategies for ABSSSITerminatedNCT03372941Phase 41 country
- Radiofrequency and Targeted Pressure Energy for Cellulite ReductionCompletedNCT05624216Not applicable1 country
- Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus HospitalCompletedNCT02334124Not applicable1 country
- Phase 2a Study of CG400549 for the Treatment of cABSSSI Caused by Methicillin-resistant Staphylococcus AureusCompletedNCT01593761Phase 21 country
- Adjunctive Clindamycin for Cellulitis: C4C Trial.CompletedNCT01876628Phase 41 country
- Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)CompletedNCT01252719Phase 31 country
- Improving Safety of Diagnosis and Therapy in the Inpatient SettingCompletedNCT04393909Not applicable1 country
- A Phase Ⅱ Clinical Study of 9MW1411 Injection in Acute Bacterial Skin and Skin Structure InfectionsStatus unknownNCT05339802Phase 21 country
- Retrospective Effectiveness Study of Dalbavancin and Other Standard of Care of the Same Class in Patients With ABSSSICompletedNCT042984632 countries
- Cantharidin Application in Molluscum Patients-1CompletedNCT03377790Phase 31 country
- Cantharidin Application in Molluscum PatientsCompletedNCT03377803Phase 31 country
- Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and DermatophytosisCompletedNCT02582177Phase 31 country